FRONTAGE HOLDINGS CORP
(HKEX: 1521)

Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. It operates through the USA and PRC segments. The USA segment includes the bioanalytical, chemistry, manufacturing and controls (CMC), drug metabolism and pharmacokinetic (DMPK), and safety and toxicology services in the USA. The PRC segment covers the bioanalytical and bioequivalence services. The company was founded by Song Li in 2001 and is headquartered in Exton, PA.

1.090 -

- (-%)
Range 1.060 - 1.090   (2.83%)
Open 1.060
Previous Close 1.090
Bid Price 1.090
Bid Volume ('000) 16
Ask Price 1.100
Ask Volume ('000) 116
Volume ('000) 56
Value 60,040
Remark -
Delayed prices. Updated at 16 Mar 2026 16:08.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis